|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/12 | |||
| A61K 31/137 | |||
| A61P 7/04 |
| (11) | Number of the document | 3010484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14735841.0 |
| Date of filing the European patent application | 2014-06-17 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/DK2014/050171 |
| Date | 2014-06-17 |
| (87) | Number | WO 2014/202088 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 201370322 | 2013-06-17 | DK |
| (72) |
HANSEN, Philip, DK
JOHANSSON, Pär, SE
KINDTLER, Jens, DK
|
| (73) |
Fremont Group Ltd,
980 North Michigan Avenue Suite 1800, Chicago, IL 60611,
US
|
| (54) | INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ADRENALINE AND CITRIC ACID |
| INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ADRENALINE AND CITRIC ACID |